| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |